Elsevier

European Urology

Volume 63, Issue 3, March 2013, Pages 519-520
European Urology

Platinum Priority
Reply from Authors re: Steven A. Kaplan. Tadalafil for the Treatment of Benign Prostatic Hyperplasia: When the Moment Does Not Add Up. Eur Urol 2013;63:517–8: Tadalafil in the Treatment of Men with Lower Urinary Tract Symptoms and/or Erectile Dysfunction Symptoms

https://doi.org/10.1016/j.eururo.2012.12.020Get rights and content

Section snippets

Conflicts of interest

Francois Giuliano is a consultant and lecturer for Eli Lilly and Company and a consultant and investigator for Bayer-Schering. Lars Viktrup is an employee and stockholder of Eli Lilly and Company. Eli Lilly and Company helped provide support for this study.

Cited by (0)

View full text